Policy & Regulation
22 April 2026 - Biotherapeutics company PureTech Health plc reported on Wednesday that its founded entity Gallop Oncology reported positive topline Phase 1b data for LYT-200 in relapsed/refractory hig...
22 April 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Wednesday that the European Commission has granted conditional marketing authorisation for Ojemda (...
22 April 2026 - Biopharmaceutical company Solvonis Therapeutics plc (LSE: SVNS) announced on Wednesday that it has appointed US-based research and investor engagement firm Water Tower Research LLC to ...
22 April 2026 - Ondine Biomedical Inc (LON: OBI), a provider of photodisinfection-based therapies, announced on Wednesday that it has secured acceptance of two abstracts for poster presentation at the...
22 April 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Wednesday that it has signed a contract with ILiAD Biotechnologies Inc to conduct a pivotal Phase III human challenge tri...
22 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved an expanded indication for Tz...